Related Experiment Video

Updated: Apr 4, 2026

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.8K

Vaccines, Adjuvants, and Dendritic Cell Activators--Current Status and Future Challenges

Joseph Obeid1, Yinin Hu1, Craig L Slingluff1

  • 1Department of Surgery, University of Virginia, Charlottesville, VA.

Seminars in Oncology
|August 31, 2015
PubMed

Insights

Cancer vaccines are a promising, low-toxicity treatment for inducing anticancer immune responses. Future research focuses on optimizing antigens, adjuvants, and combination therapies for early-stage and advanced cancers.

Area of Science:

  • Immunology
  • Oncology
  • Vaccinology

Background:

  • Cancer vaccines represent a low-toxicity strategy to stimulate anticancer immune responses.
  • One cancer vaccine is approved in the U.S. for advanced prostate cancer.
  • Renewed interest exists in optimizing cancer vaccines for early-stage cancer recurrence prevention and combination therapy for advanced cancers.

Purpose of the Study:

  • To summarize the current landscape of cancer vaccine therapy.
  • To outline the challenges and opportunities in developing effective cancer vaccines.
  • To highlight promising future directions for cancer vaccine research and application.

Main Methods:

  • Review of current practices in cancer vaccine therapy.
  • Analysis of challenges in antigen selection, adjuvant optimization, and dendritic cell activation.
  • Exploration of combination therapy strategies.

Main Results:

  • Cancer vaccines have demonstrated potential for clinical benefit, particularly in advanced prostate cancer.
  • The integration of other immunotherapies has increased enthusiasm for optimizing cancer vaccines.
  • Advancements are expected through improved antigen formulations, adjuvant use, and dendritic cell activation.

Conclusions:

  • Cancer vaccine therapy is evolving, with significant potential for preventing recurrence and treating advanced malignancies.
  • Future progress hinges on refining vaccine components, enhancing immune cell activation, and strategic combination approaches.
  • Optimizing cancer vaccines is crucial for advancing immunotherapeutic strategies against various cancers.

More Related Videos

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

11.0K
Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation08:08

Optimized Protocol for Efficient Transfection of Dendritic Cells without Cell Maturation

Published on: July 8, 2011

21.1K

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
54.0K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
49
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.4K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K